Cargando…

Serum canine thymus and activation‐regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis

BACKGROUND: Thymus and activation‐regulated chemokine (TARC/CCL17) has been implicated in the pathogenesis of canine atopic dermatitis (cAD). Serum TARC concentrations are a reliable biomarker for human atopic dermatitis; however, their potential as a biomarker for cAD has not been investigated. HYP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asahina, Ryota, Ueda, Kazunori, Oshima, Yuri, Kanei, Toshitaka, Kato, Masahiro, Furue, Masutaka, Tsukui, Toshihiro, Nagata, Masahiko, Maeda, Sadatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Hypersensitivity Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756442/ https://www.ncbi.nlm.nih.gov/pubmed/32945018 http://dx.doi.org/10.1111/vde.12894

Ejemplares similares

Altered plasma cytokines in dogs with atopic dermatitis
por: Mazrier, Hamutal, et al.
Publicado: (2021)

The effect of a mixed cannabidiol and cannabidiolic acid based oil on client‐owned dogs with atopic dermatitis
por: Loewinger, Melissa, et al.
Publicado: (2022)

A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine‐month controlled study
por: Watson, Adrian, et al.
Publicado: (2021)

Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases
por: Fennis, Evelien E. M., et al.
Publicado: (2022)

An international seroprevalence survey of the IgE sensitisation to the Dermatophagoides farinae house dust mite and two of its major allergens (Der f 2, Zen 1) in atopic dogs
por: Favrot, Claude, et al.
Publicado: (2021)

A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis
por: Van Brussel, Leen, et al.
Publicado: (2021)

Detection and Inhibition of IgE for cross‐reactive carbohydrate determinants evident in an enzyme‐linked immunosorbent assay for detection of allergen‐specific IgE in the sera of dogs and cats
por: Lee, Kenneth W., et al.
Publicado: (2020)

The usefulness of a hydrolysed fish and rice starch elimination diet for the diagnosis of adverse food reactions in cats: an open clinical trial
por: Noli, Chiara, et al.
Publicado: (2021)

Evaluation of the theoretical risk of cross‐reactivity among recently identified food allergens for dogs
por: Olivry, Thierry, et al.
Publicado: (2022)

Thymus and activation-regulated chemokine (TARC)/CCL17 and IgE are associated with elderly asthmatics
por: Jo, Kyung Mi, et al.
Publicado: (2018)

Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2020)

Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter
por: Liddiard, Kate, et al.
Publicado: (2006)

Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2021)

Expression and functional analysis of chemokine receptor 7 in canine lymphoma cell lines
por: KANEI, Toshitaka, et al.
Publicado: (2021)

Thymus and activation‐regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022)

OX40L–OX40 Signaling in Atopic Dermatitis
por: Furue, Masutaka, et al.
Publicado: (2021)

Topical tacrolimus as treatment of atopic dermatitis
por: Furue, Masutaka, et al.
Publicado: (2009)

Special Issue “Pathogenesis, Epidemiology and Treatment of Atopic Dermatitis and Psoriasis”
por: Furue, Masutaka
Publicado: (2021)

T027: High serum levels of Thymus and Activation Related Chemokine (TARC) precede Hodgkin lymphoma diagnosis by several years
por: Diepstra, Arjan, et al.
Publicado: (2022)

Variants of C-C Motif Chemokine 22 (CCL22) Are Associated with Susceptibility to Atopic Dermatitis: Case-Control Studies
por: Hirota, Tomomitsu, et al.
Publicado: (2011)

Current status of atopic dermatitis in Japan
por: Furue, Masutaka, et al.
Publicado: (2011)

IL-4 Augments IL-31/IL-31 Receptor Alpha Interaction Leading to Enhanced Ccl 17 and Ccl 22 Production in Dendritic Cells: Implications for Atopic Dermatitis
por: Miake, Sho, et al.
Publicado: (2019)

CCL17/TARC and CCR4 expression in Merkel cell carcinoma
por: Rasheed, Kashif, et al.
Publicado: (2018)

Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2019)

Analytical Performance of a Novel Latex Turbidimetric Immunoassay, “Nanopia TARC”, for TARC/CCL17 Measurement: A Retrospective Observational Study
por: Yamashita, Keita, et al.
Publicado: (2023)

Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
por: Yogo, Yurika, et al.
Publicado: (2009)

Assessment of Mucosa-Associated Epithelial Chemokine, Thymus-Expressed Chemokine, Periostin and Zonulin Levels in Infants With Atopic Dermatitis
por: Koksal, Burcu Tahire, et al.
Publicado: (2022)

TOF and TARC
Publicado: (2000)

Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis
por: Furue, Masutaka
Publicado: (2020)

Subcorneal Pustular Dermatosis Exhibiting a High Serum TARC/CCL17 Level
por: Ono, Sachiko, et al.
Publicado: (2013)

Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis
por: Goldie, Stephen J., et al.
Publicado: (2018)

The Intestinal Chemokine Thymus-expressed Chemokine (CCL25) Attracts IgA Antibody-secreting Cells
por: Bowman, Edward P., et al.
Publicado: (2002)

Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis
por: Furue, Masutaka
Publicado: (2020)

What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?
por: Catherine, Julien, et al.
Publicado: (2021)

Is CC Chemokine Ligand 17 (TARC) Driving Disease Progression in Chronic Obstructive Pulmonary Disease?
por: Girkin, Jason
Publicado: (2022)

Memorandum: Completion of the TARC experiment
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1997)

Patient-oriented Eczema Measure score: A Useful Tool for Web-Based Surveys in Patients with Atopic Dermatitis
por: KIDO-NAKAHARA, Makiko, et al.
Publicado: (2020)

Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study
por: Mihara, Ryosuke, et al.
Publicado: (2019)

The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B‐cell lymphoma and enhances T‐cell recruitment
por: Yuan, Hepei, et al.
Publicado: (2021)

Pyoderma gangrenosum after trauma in a dog
por: NAGATA, Noriyuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nh5fc01ko4tv5n39enie6kb22j